{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:14Z","timestamp":1786997894283,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.vaccine.2016.05.005","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T00:57:19Z","timestamp":1462928239000},"page":"3283-3290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Impaired innate, humoral, and cellular immunity despite a take in smallpox vaccine recipients"],"prefix":"10.1016","volume":"34","author":[{"given":"Richard B.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna G.","family":"Ovsyannikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann L.","family":"Oberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan W.","family":"Asmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane E.","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Vierkant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.05.005_bib0265","series-title":"Smallpox and its eradication","author":"Fenner","year":"1988"},{"key":"10.1016\/j.vaccine.2016.05.005_bib0270","series-title":"An inquiry into the causes and effects of the variolae vaccinae, a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of the cow pox","author":"Jenner","year":"1798"},{"issue":"June (22)","key":"10.1016\/j.vaccine.2016.05.005_bib0275","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1001\/jama.281.22.2127","article-title":"Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"281","author":"Henderson","year":"1999","journal-title":"J Am Med Assoc"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2016.05.005_bib0280","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1056\/NEJMp038208","article-title":"Poxvirus zoonoses \u2013 putting pocks into context","volume":"350","author":"Frey","year":"2004","journal-title":"N Engl J Med"},{"issue":"November (Suppl. 4)","key":"10.1016\/j.vaccine.2016.05.005_bib0285","doi-asserted-by":"crossref","first-page":"D73","DOI":"10.1016\/j.vaccine.2009.07.103","article-title":"Smallpox vaccines for biodefense","volume":"27","author":"Kennedy","year":"2009","journal-title":"Vaccine"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2016.05.005_bib0290","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.coi.2009.04.004","article-title":"The immunology of smallpox vaccines","volume":"21","author":"Kennedy","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"October (1)","key":"10.1016\/j.vaccine.2016.05.005_bib0295","article-title":"The smallpox vaccine induces an early neutralizing IgM response","volume":"28","author":"Moyron-Quiroz","year":"2009","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2016.05.005_bib0300","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1128\/IAI.19.1.34-39.1978","article-title":"Humoral and cell-mediated immune responses in humans before and after revaccination with vaccinia virus","volume":"19","author":"Moller-Larsen","year":"1978","journal-title":"Infect Immun"},{"issue":"June","key":"10.1016\/j.vaccine.2016.05.005_bib0305","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.0105-2896.2006.00392.x","article-title":"Immunity and immunological memory following smallpox vaccination","volume":"211","author":"Amanna","year":"2006","journal-title":"Immunol Rev"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2016.05.005_bib0310","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20032083","article-title":"Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans","volume":"199","author":"Combadiere","year":"2004","journal-title":"J Exp Med"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2016.05.005_bib0315","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/380906","article-title":"Dose-dependent neutralizing-antibody responses to vaccinia","volume":"189","author":"Belshe","year":"2004","journal-title":"J Infect Dis"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2016.05.005_bib0320","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J Immunol"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2016.05.005_bib0325","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.2000.0750","article-title":"Antibody neutralization of the extracellular enveloped form of vaccinia virus","volume":"280","author":"Law","year":"2001","journal-title":"Virology"},{"issue":"July (14)","key":"10.1016\/j.vaccine.2016.05.005_bib0330","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1128\/JVI.00353-08","article-title":"Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice","volume":"82","author":"Kaufman","year":"2008","journal-title":"J Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2016.05.005_bib0335","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.icb.7100118","article-title":"Correlates of protective immunity in poxvirus infection: where does antibody stand?","volume":"86","author":"Panchanathan","year":"2008","journal-title":"Immunol Cell Biol"},{"issue":"5","key":"10.1016\/j.vaccine.2016.05.005_bib0340","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0035-9203(72)90095-8","article-title":"Relationship of clinical severity, antibody level, and previous vaccination state in smallpox","volume":"66","author":"Sarkar","year":"1972","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2016.05.005_bib0345","first-page":"307","article-title":"The minimum protective level of antibodies in smallpox","volume":"52","author":"Sarkar","year":"1975","journal-title":"Bull World Health Organ"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2016.05.005_bib0350","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1972.21.214","article-title":"A prospective study of serum antibody and protection against smallpox","volume":"21","author":"Mack","year":"1972","journal-title":"Am J Trop Med Hyg"},{"issue":"Spring (1)","key":"10.1016\/j.vaccine.2016.05.005_bib0355","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/vim.1990.3.19","article-title":"Correlation between cutaneous reaction in vaccinees immunized against smallpox and antibody titer determined by plaque neutralization test and ELISA","volume":"3","author":"Lublin-Tennenbaum","year":"1990","journal-title":"Viral Immunol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2016.05.005_bib0360","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1128\/CVI.00109-09","article-title":"Statistical approach to estimate vaccinia-specific neutralizing antibody titers using a high-throughput assay","volume":"16","author":"Kennedy","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"February (11)","key":"10.1016\/j.vaccine.2016.05.005_bib0365","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00251-004-0756-0","article-title":"HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine","volume":"56","author":"Ovsyannikova","year":"2005","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2016.05.005_bib0370","article-title":"Generation of recombinant vaccinia viruses","author":"Earl","year":"2001","journal-title":"Curr Protoc Protein Sci"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2016.05.005_bib0375","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JVI.70.1.165-171.1996","article-title":"Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light","volume":"70","author":"Tsung","year":"1996","journal-title":"J Virol"},{"issue":"February (1\u20132)","key":"10.1016\/j.vaccine.2016.05.005_bib0380","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jim.2008.11.001","article-title":"Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination","volume":"341","author":"Ryan","year":"2009","journal-title":"J Immunol Methods"},{"issue":"October (45)","key":"10.1016\/j.vaccine.2016.05.005_bib0385","doi-asserted-by":"crossref","first-page":"7883","DOI":"10.1016\/j.vaccine.2011.08.083","article-title":"Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination","volume":"29","author":"Haralambieva","year":"2011","journal-title":"Vaccine"},{"issue":"March (1\u20132)","key":"10.1016\/j.vaccine.2016.05.005_bib0390","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jim.2011.01.011","article-title":"Optimizing high dimensional gene expression studies for immune response following smallpox vaccination using Taqman(R) low density immune arrays","volume":"366","author":"Oberg","year":"2011","journal-title":"J Immunol Methods"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2016.05.005_bib0395","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00439-012-1174-2","article-title":"Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients","volume":"131","author":"Kennedy","year":"2012","journal-title":"Hum Genet"},{"key":"10.1016\/j.vaccine.2016.05.005_bib0400","series-title":"Methods in molecular biology","first-page":"213","article-title":"Linear mixed effects models","author":"Oberg","year":"2009"},{"key":"10.1016\/j.vaccine.2016.05.005_bib0405","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"issue":"February","key":"10.1016\/j.vaccine.2016.05.005_bib0410","article-title":"Gender effects on humoral immune responses to smallpox vaccine","volume":"27","author":"Kennedy","year":"2009","journal-title":"Vaccine"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2016.05.005_bib0415","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/infdis\/jiq162","article-title":"Smallpox vaccine safety is dependent on T cells and not B cells","volume":"203","author":"Gordon","year":"2011","journal-title":"J Infect Dis"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2016.05.005_bib0420","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"issue":"April (17)","key":"10.1016\/j.vaccine.2016.05.005_bib0425","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa013431","article-title":"Dose-related effects of smallpox vaccine","volume":"346","author":"Frey","year":"2002","journal-title":"N Engl J Med"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2016.05.005_bib0430","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/infdis\/jis546","article-title":"High-dimensional gene expression profiling studies in high and low responders to primary smallpox vaccination","volume":"206","author":"Haralambieva","year":"2012","journal-title":"J Infect Dis"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2016.05.005_bib0435","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1086\/423848","article-title":"Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination","volume":"190","author":"Kennedy","year":"2004","journal-title":"J Infect Dis"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2016.05.005_bib0440","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.humimm.2013.06.031","article-title":"Race and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individuals","volume":"74","author":"Haralambieva","year":"2013","journal-title":"Hum Immunol"},{"issue":"October (41)","key":"10.1016\/j.vaccine.2016.05.005_bib0445","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1016\/j.vaccine.2015.08.032","article-title":"Sex difference in immune response to vaccination: a participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine","volume":"33","author":"Troy","year":"2015","journal-title":"Vaccine"},{"issue":"March (14)","key":"10.1016\/j.vaccine.2016.05.005_bib0450","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.vaccine.2016.02.036","article-title":"Sex-dependent immune responses to infant vaccination: an individual participant data meta-analysis of antibody and memory B cells","volume":"34","author":"Voysey","year":"2016","journal-title":"Vaccine"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2016.05.005_bib0455","first-page":"408","article-title":"Sex and gender impact immune responses to vaccines among the elderly","volume":"30","author":"Fink","year":"2015","journal-title":"Physiology (Bethesda)"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2016.05.005_bib0460","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1086\/651453","article-title":"Kinetics of serum cytokines after primary or repeat vaccination with the smallpox vaccine","volume":"201","author":"Cohen","year":"2010","journal-title":"J Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2016.05.005_bib0465","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1128\/JVI.73.2.1479-1491.1999","article-title":"The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity in vivo","volume":"73","author":"Mahalingam","year":"1999","journal-title":"J Virol"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2016.05.005_bib0470","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1152\/physrev.00035.2007","article-title":"Evolution and function of the ADP ribosyl cyclase\/CD38 gene family in physiology and pathology","volume":"88","author":"Malavasi","year":"2008","journal-title":"Physiol Rev"},{"issue":"October (20)","key":"10.1016\/j.vaccine.2016.05.005_bib0475","doi-asserted-by":"crossref","first-page":"10151","DOI":"10.1128\/JVI.02670-05","article-title":"CD127+ CCR5+ CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells","volume":"80","author":"Zaunders","year":"2006","journal-title":"J Virol"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2016.05.005_bib0480","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2016.05.005_bib0485","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.4049\/jimmunol.179.6.3917","article-title":"IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17","volume":"179","author":"Kohyama","year":"2007","journal-title":"J Immunol"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2016.05.005_bib0490","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.4049\/jimmunol.1000818","article-title":"Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype","volume":"185","author":"Yeh","year":"2010","journal-title":"J Immunol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2016.05.005_bib0495","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/jir.2009.0073","article-title":"The interferon system and vaccinia virus evasion mechanisms","volume":"29","author":"Perdiguero","year":"2009","journal-title":"J Interferon Cytokine Res"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2016.05.005_bib0500","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1074-7613(01)00126-1","article-title":"Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo","volume":"14","author":"Le Bon","year":"2001","journal-title":"Immunity"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2016.05.005_bib0505","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.09.55","article-title":"The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks","volume":"8","author":"Handley","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"May (25)","key":"10.1016\/j.vaccine.2016.05.005_bib0510","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/j.vaccine.2005.01.079","article-title":"A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults","volume":"23","author":"Artenstein","year":"2005","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2016.05.005_bib0515","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/CVI.05521-11","article-title":"Failure of the smallpox vaccine to develop a skin lesion in vaccinia virus-naive individuals is related to differences in antibody profiles before vaccination, not after","volume":"19","author":"Tan","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2016.05.005_bib0520","doi-asserted-by":"crossref","first-page":"e1003989","DOI":"10.1371\/journal.ppat.1003989","article-title":"Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS\/STING-mediated cytosolic DNA-sensing pathway","volume":"10","author":"Dai","year":"2014","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16302778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16302778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T05:24:45Z","timestamp":1718515485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16302778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":52,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0264410X16302778"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.05.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired innate, humoral, and cellular immunity despite a take in smallpox vaccine recipients","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}